The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

Body-acceptance advocate Katie Sturino and Ronald Young Jr., host of the podcast Weight for It, answer listener questions ...

New study reveals adding whey protein to dual-source carbohydrates enhances amino acid availability without compromising ...

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is linked to improved clinical outcomes compared with conventional therapies.

Because glucagon in animals has positive inotropic and chronotropic effects in the presence of beta-adrenergic blockade, catecholamine depletion or full digitalization, its cardiovascular effects i ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes ...